OLIPHANT LAURA sold $228K of AEHR
OLIPHANT LAURA (Director) sold 1,717 shares of AEHR TEST SYSTEMS (AEHR) at $133.00 ($0.23M total) on 2026-08-12.
How this was made
The 30-second read
Why it matters
The newest fact is the director’s open-market sale details (shares, price, total value, and post-transaction holdings). This typically has limited trading impact unless unusually large or paired with other company news.
Market read
Traders may note the insider selling signal, but the disclosure alone does not provide new guidance, contracts, or regulatory developments.
What to watch
The article does not state whether the director’s remaining stake is meaningful, nor does it provide context on prior sales or compensation structure.
Background
The article is a SEC Form 4 insider transaction disclosure for AEHR Test Systems.
Ticker impact
AEHR director Laura Oliphant filed a Form 4 open-market sale of 1,717 shares at $133, totaling about $228K.
Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.
The filing discloses transaction size, price, and post-sale holdings, but provides no new operational or guidance information.
Market effects
No clear sector read-through from a single, modest insider sale.
None indicated.
None indicated.
Counterpoint
Insider sales can be routine liquidity events; without a 10b5-1 plan, the sale could still be non-informational (taxes, diversification).
Key entities
- issuerAEHR Test Systems
Company whose director insider sale is disclosed via SEC Form 4.
- insiderLaura Oliphant
Director who sold 1,717 shares at $133/share.
